25-hydroxycholesterol induces lipopolysaccharide-tolerance and decreases a lipopolysaccharide-induced TNF-alpha secretion in macrophages.

[1]  B. Staels,et al.  Induction of IκBα Expression as a Mechanism Contributing to the Anti-inflammatory Activities of Peroxisome Proliferator-activated Receptor-α Activators* , 2000, The Journal of Biological Chemistry.

[2]  D. Mangelsdorf,et al.  Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. , 2000, Science.

[3]  D. Mangelsdorf,et al.  Human White/Murine ABC8 mRNA Levels Are Highly Induced in Lipid-loaded Macrophages , 2000, The Journal of Biological Chemistry.

[4]  B. Spiegelman,et al.  PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro , 1999 .

[5]  H. Ziegler-Heitbrock,et al.  NF-κB1 (p50) Is Upregulated in Lipopolysaccharide Tolerance and Can Block Tumor Necrosis Factor Gene Expression , 1999, Infection and Immunity.

[6]  Andrew J. Brown,et al.  Oxysterols and atherosclerosis. , 1999, Atherosclerosis.

[7]  J. Peters,et al.  Expression of Putative Fatty Acid Transporter Genes Are Regulated by Peroxisome Proliferator-activated Receptor α and γ Activators in a Tissue- and Inducer-specific Manner* , 1998, The Journal of Biological Chemistry.

[8]  C. Glass,et al.  Expression of the peroxisome proliferator-activated receptor γ (PPARγ) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein , 1998 .

[9]  R. Evans,et al.  PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL , 1998, Cell.

[10]  R. Evans,et al.  Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ , 1998, Cell.

[11]  B. Seed,et al.  PPAR-γ agonists inhibit production of monocyte inflammatory cytokines , 1998, Nature.

[12]  Christopher K. Glass,et al.  The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation , 1998, Nature.

[13]  I. Björkhem,et al.  Elimination of Cholesterol in Macrophages and Endothelial Cells by the Sterol 27-Hydroxylase Mechanism , 1997, The Journal of Biological Chemistry.

[14]  P. Nataf,et al.  Effect of the oxidation state of LDL on the modulation of arterial vasomotor response in vitro. , 1997, Atherosclerosis.

[15]  Daniel Steinberg,et al.  Low Density Lipoprotein Oxidation and Its Pathobiological Significance* , 1997, The Journal of Biological Chemistry.

[16]  D. Mangelsdorf,et al.  Activation of the orphan nuclear receptor steroidogenic factor 1 by oxysterols. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Timothy M. Willson,et al.  Activation of the Nuclear Receptor LXR by Oxysterols Defines a New Hormone Response Pathway* , 1997, The Journal of Biological Chemistry.

[18]  O. Wiklund,et al.  Macrophages isolated from human atherosclerotic plaques produce IL-8, and oxysterols may have a regulatory function for IL-8 production. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[19]  M. Wilson,et al.  Formation of oxysterols during oxidation of low density lipoprotein by peroxynitrite, myoglobin, and copper. , 1996, Journal of lipid research.

[20]  D. Mangelsdorf,et al.  An oxysterol signalling pathway mediated by the nuclear receptor LXRα , 1996, Nature.

[21]  B. Ohlsson,et al.  Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-kappaB to DNA and the subsequent expression of tumor necrosis factor-alpha and interleukin-1beta in macrophages. , 1996, The Journal of clinical investigation.

[22]  L. Lania,et al.  Sp3 Represses Transcription When Tethered to Promoter DNA or Targeted to Promoter Proximal RNA (*) , 1996, The Journal of Biological Chemistry.

[23]  P. Grimaldi,et al.  Expression of the CD36 homolog (FAT) in fibroblast cells: effects on fatty acid transport. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. Knuechel,et al.  Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. , 1996, The Journal of clinical investigation.

[25]  H. Lindmark,et al.  Oxysterols present in atherosclerotic tissue decrease the expression of lipoprotein lipase messenger RNA in human monocyte-derived macrophages. , 1996, The Journal of clinical investigation.

[26]  M. Goldman,et al.  Defective translation of tumor necrosis factor mRNA in lipopolysaccharide-tolerant macrophages. , 1996, Journal of inflammation.

[27]  L. Lania,et al.  Differential transcriptional regulation of c-myc promoter through the same DNA binding sites targeted by Sp1-like proteins. , 1995, Oncogene.

[28]  S. Yamamoto,et al.  Suppression of TNF-alpha mRNA expression in LPS-primed macrophages occurs at the level of nuclear factor-kappa B activation, but not at the level of protein kinase C or CD14 expression. , 1995, Journal of immunology.

[29]  W. J. Johnson,et al.  Inhibition of cellular cholesterol efflux by 25-hydroxycholesterol. , 1995, Journal of lipid research.

[30]  U. Diczfalusy,et al.  Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. , 1995, Analytical biochemistry.

[31]  L. Lania,et al.  Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1. , 1994, Nucleic acids research.

[32]  O. Andersson,et al.  Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. Beato,et al.  Sp1‐mediated transcriptional activation is repressed by Sp3. , 1994, The EMBO journal.

[34]  T. Yue,et al.  Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells. , 1994, Circulation research.

[35]  P. Baeuerle,et al.  Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.

[36]  J. Hiscott,et al.  Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop , 1993, Molecular and cellular biology.

[37]  T. Yue,et al.  Interleukin-8 is chemotactic for vascular smooth muscle cells. , 1993, European journal of pharmacology.

[38]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[39]  P. Libby,et al.  Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. , 1992, The American journal of pathology.

[40]  D. Steinberg,et al.  Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Z. Rymaszewski,et al.  Oxidation of cholesterol moiety of low density lipoprotein in the presence of human endothelial cells or Cu+2 ions: identification of major products and their effects. , 1991, Biochemical and biophysical research communications.

[42]  P. Baeuerle,et al.  Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B , 1990, Molecular and cellular biology.

[43]  C V Jongeneel,et al.  Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages , 1990, The Journal of experimental medicine.

[44]  M. V. Doyle,et al.  Quantitation of mRNA by the polymerase chain reaction. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J L Witztum,et al.  Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. , 1989, The Journal of clinical investigation.

[46]  E. Appella,et al.  The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. , 1989, Science.

[47]  F. Taylor,et al.  Correlation between oxysterol binding to a cytosolic binding protein and potency in the repression of hydroxymethylglutaryl coenzyme A reductase. , 1984, Journal of Biological Chemistry.

[48]  J L Witztum,et al.  Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[49]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[50]  A. Bøyum.  Isolation of lymphocytes, granulocytes and macrophages. , 1976, Scandinavian journal of immunology.

[51]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[52]  J. Goldstein,et al.  Regulation of the activity of the low density lipoprotein receptor in human fibroblasts , 1975, Cell.